000 | 01409 a2200385 4500 | ||
---|---|---|---|
005 | 20250516051110.0 | ||
264 | 0 | _c20111025 | |
008 | 201110s 0 0 jpn d | ||
022 | _a0917-5857 | ||
024 | 7 |
_aCliCa110811671174 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbe, Masahiro | |
245 | 0 | 0 |
_a[Myeloma bone disease and RANKL signaling]. _h[electronic resource] |
260 |
_bClinical calcium _cAug 2011 |
||
300 |
_a1167-74 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xphysiology |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aBone Resorption _xgenetics |
650 | 0 | 4 |
_aCell Differentiation _xgenetics |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xphysiology |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
650 | 0 | 4 |
_aOsteoblasts _xcytology |
650 | 0 | 4 |
_aOsteoclasts _xcytology |
650 | 0 | 4 |
_aRANK Ligand _ximmunology |
650 | 0 | 4 |
_aRepressor Proteins _xphysiology |
650 | 0 | 4 |
_aSignal Transduction _xphysiology |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xphysiology |
773 | 0 |
_tClinical calcium _gvol. 21 _gno. 8 _gp. 1167-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/CliCa110811671174 _zAvailable from publisher's website |
999 |
_c21059363 _d21059363 |